Home
Screener
WINT
profile

WINT Company Profile and Key Details

NASDAQ : WINT

Windtree Therapeutics, Inc.

$0.12

-0.006-4.78%

At Close 4:00 PM

$0.13

0.01+8.36%

Pre-Market 04:40 AM

67.99

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

WINT Stock Price Chart

Stock Price Today

Windtree Therapeutics, Inc. (WINT) stock declined over -4.78%, trading at $0.12 on NASDAQ, down from the previous close of $0.13. The stock opened at $0.12, fluctuating between $0.10 and $0.14 in the recent session.

Stock Snapshot

0.1256

Prev. Close

0.12

Open

1.32M

Market Cap

11.05M

Number of Shares

0.1046

Day Low

0.1433

Day High

-0.01

P/E Ratio

99.48%

Free Float in %

-22.01

EPS (TTM)

0.57

Book Value

-2.24

Cash Flow per Share

6.97M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2025	0.12	0.14	0.10	0.12	6.98M
Feb 03, 2025	0.13	0.13	0.12	0.13	1.51M
Jan 31, 2025	0.14	0.14	0.13	0.13	3.19M
Jan 30, 2025	0.14	0.14	0.13	0.13	2.3M
Jan 29, 2025	0.13	0.15	0.13	0.14	5.27M
Jan 28, 2025	0.16	0.16	0.14	0.14	4.2M
Jan 27, 2025	0.16	0.17	0.16	0.16	5.38M
Jan 24, 2025	0.20	0.33	0.17	0.18	53.82M
Jan 22, 2025	0.21	0.21	0.20	0.20	2.06M
Jan 21, 2025	0.22	0.23	0.20	0.21	1.7M
Jan 17, 2025	0.23	0.23	0.22	0.22	1.55M
Jan 16, 2025	0.23	0.24	0.22	0.23	2.19M
Jan 15, 2025	0.25	0.27	0.21	0.24	22.67M
Jan 14, 2025	0.25	0.26	0.24	0.25	1.51M
Jan 13, 2025	0.25	0.26	0.24	0.25	1.43M
Jan 10, 2025	0.27	0.28	0.26	0.26	1.89M
Jan 08, 2025	0.30	0.30	0.26	0.27	16.08M
Jan 07, 2025	0.31	0.33	0.30	0.30	3.17M
Jan 06, 2025	0.31	0.33	0.30	0.31	3.19M
Jan 03, 2025	0.34	0.36	0.31	0.32	8.61M

Contact Details

Warrington, PA 18976-3622

United States

Website: https://windtreetx.comContact: 215 488 9300

About Company

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.

Frequently Asked Questions

What is the current Windtree Therapeutics, Inc. (WINT) stock price?

Windtree Therapeutics, Inc. (NASDAQ: WINT) stock price is $0.12 in the last trading session. During the trading session, WINT stock reached the peak price of $0.14 while $0.10 was the lowest point it dropped to. The percentage change in WINT stock occurred in the recent session was -4.78% while the dollar amount for the price change in WINT stock was -$0.01.

WINT's industry and sector of operation?

The NASDAQ listed WINT is part of Biotechnology industry that operates in the broader Healthcare sector. Windtree Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of WINT?

Mr. George Cox
Vice President of Technical Operations
Dr. Ronald L. Dundore
Executive Director of Regulatory Affairs & Quality
Ms. Tracy Rarick
Head of Operations & Program Management
Dr. Pratap Paruchuru
Executive Director of Clinical Devel.
Dr. Steven G. Simonson
Senior Vice President & Chief Medical Officer
Mr. Eric L. Curtis M.B.A.
Senior Vice President & Chief Operating Officer
Mr. John A. Tattory
Interim Chief Financial Officer
Ms. Diane Carman Esq.
Senior Vice President, Gen. Counsel & Corporation Sec.
Mr. Craig E. Fraser
Chairman, Pres, Chief Executive Officer & Director
Mr. John P. Hamill CPA
Senior Vice President, Chief Financial Officer & Principal Accounting Officer

How WINT did perform over past 52-week?

WINT's closing price is 14.34% higher than its 52-week low of $0.10 where as its distance from 52-week high of $14.75 is -99.19%.

How many employees does WINT have?

Number of WINT employees currently stands at 20.

Link for WINT official website?

Official Website of WINT is: https://windtreetx.com

How do I contact WINT?

WINT could be contacted at phone 215 488 9300 and can also be accessed through its website. WINT operates from 2600 Kelly Road, Warrington, PA 18976-3622, United States.

How many shares of WINT are traded daily?

WINT stock volume for the day was 6.97M shares. The average number of WINT shares traded daily for last 3 months was 3.3M.

What is the market cap of WINT currently?

The market value of WINT currently stands at $1.32M with its latest stock price at $0.12 and 11.05M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

WINT Stock Price Chart

Stock Price Today

Stock Snapshot

0.1256

Prev. Close

0.12

Open

1.32M

Market Cap

11.05M

Number of Shares

0.1046

Day Low

0.1433

Day High

-0.01

P/E Ratio

99.48%

Free Float in %

-22.01

EPS (TTM)

0.57

Book Value

-2.24

Cash Flow per Share

6.97M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2025	0.12	0.14	0.10	0.12	6.98M
Feb 03, 2025	0.13	0.13	0.12	0.13	1.51M
Jan 31, 2025	0.14	0.14	0.13	0.13	3.19M
Jan 30, 2025	0.14	0.14	0.13	0.13	2.3M
Jan 29, 2025	0.13	0.15	0.13	0.14	5.27M
Jan 28, 2025	0.16	0.16	0.14	0.14	4.2M
Jan 27, 2025	0.16	0.17	0.16	0.16	5.38M
Jan 24, 2025	0.20	0.33	0.17	0.18	53.82M
Jan 22, 2025	0.21	0.21	0.20	0.20	2.06M
Jan 21, 2025	0.22	0.23	0.20	0.21	1.7M
Jan 17, 2025	0.23	0.23	0.22	0.22	1.55M
Jan 16, 2025	0.23	0.24	0.22	0.23	2.19M
Jan 15, 2025	0.25	0.27	0.21	0.24	22.67M
Jan 14, 2025	0.25	0.26	0.24	0.25	1.51M
Jan 13, 2025	0.25	0.26	0.24	0.25	1.43M
Jan 10, 2025	0.27	0.28	0.26	0.26	1.89M
Jan 08, 2025	0.30	0.30	0.26	0.27	16.08M
Jan 07, 2025	0.31	0.33	0.30	0.30	3.17M
Jan 06, 2025	0.31	0.33	0.30	0.31	3.19M
Jan 03, 2025	0.34	0.36	0.31	0.32	8.61M

Contact Details

Warrington, PA 18976-3622

United States

Website: https://windtreetx.comContact: 215 488 9300

About Company

Frequently Asked Questions

What is the current Windtree Therapeutics, Inc. (WINT) stock price?

WINT's industry and sector of operation?

Who are the executives of WINT?

How WINT did perform over past 52-week?

WINT's closing price is 14.34% higher than its 52-week low of $0.10 where as its distance from 52-week high of $14.75 is -99.19%.

How many employees does WINT have?

Number of WINT employees currently stands at 20.

Link for WINT official website?

Official Website of WINT is: https://windtreetx.com

How do I contact WINT?

WINT could be contacted at phone 215 488 9300 and can also be accessed through its website. WINT operates from 2600 Kelly Road, Warrington, PA 18976-3622, United States.

How many shares of WINT are traded daily?

WINT stock volume for the day was 6.97M shares. The average number of WINT shares traded daily for last 3 months was 3.3M.

What is the market cap of WINT currently?

The market value of WINT currently stands at $1.32M with its latest stock price at $0.12 and 11.05M of its shares outstanding.

Employees	20
Beta	0.64
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	20
Beta	0.64
Sales or Revenue	$0.00
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

WINT Company Profile and Key Details

Windtree Therapeutics, Inc.

WINT Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

WINT Stock Price Chart

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions